AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Laboratorios Bagó was born in Argentina and grew with the century. Since its foundation, in 1934, it assumed a commitment that accompanies us until today: build a cutting-edge pharmaceutical company and excellence in the service of health. Products in more than 50 countries, 11 production plants in the world, 85 patents obtained in 15 countries by own research and development and more than 480 products covering 46 therapeutic lines are some of the achievements that distinguish our trajectory.

Inventia Healthcare Ltd. engages in the development and manufacture of pharmaceutical formulations. It caters anti-diabetic, gastrointestinal, CVC, CNS and musculoskeletal therapeutic areas. The company was founded by Janak Shah and Maya Shah in 1985 and is headquartered in Mumbai, India.

Wuhu Tiancheng Puyang Traditional Chinese Medicine Technology Co., Ltd., established on 2014-04-03, Business scope includes Chinese patent medicine,Traditional Chinese Medicine Daily Health Products,Chinese medicine bath agent,Chinese herbal fragrance,Traditional Chinese Veterinary Medicine,Traditional Chinese Medicine Feed Additives,Traditional Chinese Medicine Daily Cosmetics,Chinese herbal drink,Research and development of new decoction pieces of traditional Chinese medicine;Research and development of traditional Chinese medicine quality control technology and related technical services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**

Part of CSPC Pharmaceutical Group Ltd., CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd. is a company headquartered in China. The firm engages in pharmaceutical research and development.

Shouguang Fukang Pharmaceutical Co. Ltd. is a Chinese private company that manufactures and distributes pharmaceutical ingredients.

Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd., established on 2006-01-26, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Pharmaceutical commissioned production;Biochemical product technology research and development;Medical Research and Experimental Development;packaging service;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Visum Pharmaceutical develops and sells high-barrier oral solid dosage drugs. It now has 2 manufacturing centers, 2 R&D centers, and 1 marketing center. The company has passed the FDA's GMP review 4 times and the NMPA's quality review 3 times. At present, 5 products have been marketed in China or the US market, and the annual export volume of sustained and controlled release preparations exceeds 400 million tablets. Huayi Taikang is a comprehensive pharmaceutical enterprise integrating R&D, production, export, and sales of high-end oral solid preparations. Foreign pharmaceutical companies expand into international markets such as China, the United States, the European Union, and WHO. The company was founded in 2010 and is based in Haikou City, China.

Ranbaxy Laboratories Limited, a pharmaceutical company, produces a range of generic medicines. The company has a presence in 49 countries, manufacturing facilities in 11 countries and serves customers in approximately 125 countries. Products The company manufactures and markets generic pharmaceuticals, value added generic pharmaceuticals, branded generics, active Pharmaceuticals (API) and intermediates. Its product basket of approximately 5,000 SKUs available in approximately 125 countries worldwide, encompasses a therapeutic mix covering a majority of the chronic and acute segments. Research & Development The company offers value added formulations based on its Novel Drug Delivery System (NDDS) and New Chemical Entity (NCE) research outcomes. Novel Drug Delivery Systems (NDDS): The company's NDDS focus is mainly on the development of New Drug Applications (NDA) / Abbreviated New Drug Applications (ANDAs) of oral controlled- release products for the regulated markets. Ranbaxy's in-house NDDS programs are primarily focused on the oral segment. Inhalation (patented devices) and trans-dermal (patented adhesive polymers) programs are also being pursued through collaborations. In the oral NDDS space, Ranbaxy has developed four platform technologies namely Gastro Retentive, Modified Matrix, Multiparticulate and AeroGel. New Drug Discovery Research (NDDR): The company's NDDR program focuses on select therapeutic segments of Infectious diseases, Metabolic diseases, Inflammatory/ Respiratory disease and Oncology. The company has 8-10 programs in the area of NDDR. For Arterolane (potential Anti-malarial candidate), the company has obtained approval from the Drug Controller General of India to initiate Phase III human clinical trials in India. The company is also profiling DPP-IV Inhibitors (Di-Peptidyl Peptidase IV Inhibitors) for Type-2-diabetes, a selective Phosphodiesterase 4-b inhibitor for COPD and Asthma, and a novel antibiotic antibacterial for Community Acquired Respiratory Tract Infection. Under an alliance with an academic institution in India, various medicinal plants are being evaluated as potential sources for novel pharmaceutical agents. The company also has collaborative research projects with other academic institutions in India in the area of Respiratory and Infectious disease. Significant Events In June 2008, Ranbaxy entered into an alliance with Daiichi Sankyo Company Ltd., to create a generic pharmaceutical powerhouse. On September 17, 2009, Ranbaxy Laboratories Ltd. has entered into a strategic in-licensing agreement for the Indian market with Medy-Tox Inc. for its cosmetic product, Neuronox. Neuronox is a botulinum toxin type A complex (100 Units) pharmaceutical manufactured by Medy-Tox. History Ranbaxy Laboratories Limited was founded in 1961.

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the manufacture, research and development, and marketing of pharmaceutical drugs. Its products include valsartan, irbesartan, candesartan cilexetil, olmesartan medoxomil, piperaquine phosphate, voriconazole, lansoprazole, rabeprazole sodium, dasatinib, and gefitinib. The company was founded on December 30, 1999 and is headquartered in Zhuhai, China.

Sanovel Ila�� Sanayi ve Ticaret AS engages in the manufacture of pharmaceutical products. It develops medicaments, such as antihistamines, expectorants, decongestants, antibiotics, and anti-inflammatory drugs, as well as offers research and development services. The company was founded by Erol Toks��z in 1983 and is headquartered in Istanbul, Turkey.

Zhongshuai Pharmaceutical Sci & Tech Co., Ltd. (doing business as Henan Zhongshuai Pharmaceutical Technology Co., Ltd.) is a Chinese private company located in Zhengzhou. The firm manufactures pharmaceutical products.

Santa Farma Ila�� Sanayii AS is a private company headquartered in Sisli, Turkey, that manufactures pharmaceutical products.

China Chemical & Pharmaceutical Co., Ltd. engages in the business of buying, selling, manufacturing, importing, and exporting pharmaceutical products. It operates under the Taiwan and China geographical segments. The company was founded by Ming Ning Wang on March 12, 1952 and is headquartered in Taipei, Taiwan.

Yung Shin Pharm Ind Kunshan Co. Ltd. is a Chinese private company located in Kunshan. The firm produces aspirin enteric-coated capsules.

Established in 1987, Korea United Pharm. Inc. has continued to develop as a pharmaceutical company with its slogan of "Korean owned multinational pharmaceutical company." We have continuously launched new pharmaceutical drugs such as Cilostan CR Tab, Gastiin CR Tab, Clanza CR Tab and etc., through prestigious R&D investment, abundant know-hows and top expert researchers and have been placed as a strong competitor in the pharmaceutical drug development industry. they were named one of Asia's 200 most promising companies by the US economy magazine Forbes.

Guangzhou Gonghe Pharmaceutical Technology Co., Ltd., established on 2010-07-08, Business scope includes medical research and experimental development;Engineering and Technology Research and Experimental Development;Natural science research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;New material technology promotion service;Engineering technical service(planning management,survey,design,Except supervision);Information Consulting Service(Not including licensing information consulting services);Pharmaceutical special equipment sales;Drug testing equipment sales;Sales of Class I Medical Devices;Cosmetics Retail;Cosmetics Wholesale;Sales of daily chemical products;Personal Hygiene Sales;Sales of graphite and carbon products;Production of Class I Medical Devices;Sales of formula food for special medical purposes;pharmaceutical production;Pharmaceutical commissioned production;Import and export;Technology Import and Export;Drug retail;Health food sales;Food Internet Sales(Selling prepackaged food);food business;food production;Cosmetic production;Health food production;Production of hygiene products and single-use medical products;Production of formula food for special medical purpose

Zhuhai Tiancheng Traditional Chinese Medicine Co., Ltd., established on 2017-02-06, Business scope includes

Wuhan Wuyao Technology Co., Ltd., established on 2003-06-10, Business scope includes pharmaceutical,chemical industry,medical instruments,product technology development,technology transfer,Technical Services,technical consulting.

Kangmei Baoning (Sichuan) Pharmaceutical Co., Ltd., established on 1999-05-24, Business scope includes raw materials(glucose),Granules,hard capsule,tablet,Powder,syrup,tincture,pill,Decoction,medical supplements(starch,dextrin)Production,Sales,Oral glucose series,general food production,Sales,Manage the export business of the company's self-produced products and technologies,Raw and auxiliary materials required for the production of the enterprise,Instrumentation,Equipment,Import business of spare parts and technology(Except for goods and technologies that are restricted by the state to operate by the company and prohibited by the state from import and export),operating incoming material processing and"Three to one make up"business,R&D service,Professional technical service,real estate lease,Conference and Exhibition Services,Chinese herbal medicine planting(Except for species prohibited by the state),buy,Sales,foreign trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)